quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:22:00·1248d
NEWSRelease
Achieve Life Sciences Inc. logo
Biofrontera Inc. logo
Cosmos Health Inc. logo
+16

Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket

ACHV· Achieve Life Sciences Inc.BFRI· Biofrontera Inc.COSM· Cosmos Health Inc.CYCN· Cyclerion Therapeutics Inc.DS· Drive Shack Inc.EQOS· EQONEX LIMITED
Health CareReal EstateConsumer Discretionary
Original source

Companies

  • ACHV
    Achieve Life Sciences Inc.
    Health Care
  • BFRI
    Biofrontera Inc.
    Health Care
  • COSM
    Cosmos Health Inc.
    Health Care
  • CYCN
    Cyclerion Therapeutics Inc.
    Health Care
  • DS
    Drive Shack Inc.
    Real Estate
  • EQOS
    EQONEX LIMITED
    Consumer Discretionary
  • FWBI
    First Wave BioPharma Inc.
    Health Care
  • GMBL
    Esports Entertainment Group Inc.
    Consumer Discretionary
  • GMDA
    Gamida Cell Ltd.
    Health Care
  • GOEV
    Canoo Inc.
    Consumer Discretionary
  • GOTU
    Gaotu Techedu Inc.
    Real Estate
  • HILS
    Hillstream BioPharma Inc.
    Health Care
  • MMAT
    Meta Materials Inc.
    Technology
  • OBSV
    ObsEva SA
    Health Care
  • SECO
    Secoo Holding Limited
    Miscellaneous
  • SYTA
    Siyata Mobile Inc.
    Telecommunications
  • TANH
    Tantech Holdings Ltd.
    Industrials
  • VERO
    Venus Concept Inc.
    Health Care
  • ZM
    Zoom Communications Inc.
    Technology

Recent analyst ratings

  • Apr 21ACHVUpdateCanaccord Genuity$13.00
  • Feb 5ZMUpdateWolfe Research$115.00
  • Jan 12ZMUpdateCitigroup$106.00
  • Dec 17ZMUpdateBTIG Research$105.00
  • Nov 25ACHVUpdateCitizens JMP$19.00
  • Oct 21ZMUpdateMorgan Stanley$85.00

Related

  • PR1d
    Gaotu Techedu Files Its Annual Report on Form 20-F
  • SEC1d
    SEC Form 20-F filed by Gaotu Techedu Inc.
  • INSIDER2d
    SEC Form 4 filed by Goldberg Andrew D.
  • INSIDER2d
    SEC Form 3 filed by new insider Goldberg Andrew D.
  • INSIDER2d
    SEC Form 4 filed by Bawa Aparna
  • NEWS2d
    Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products
  • ANALYST2d
    Canaccord Genuity initiated coverage on Achieve Life Sciences with a new price target
  • INSIDER3d
    SEC Form 4 filed by Subotovsky Santiago
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022